Radnor Capital Management, LLC Organon & Co. Transaction History

Radnor Capital Management, LLC

$586 Million
Q1 2024

A detailed history of Radnor Capital Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Radnor Capital Management, LLC holds 45,585 shares of OGN stock, worth $925,831. This represents 0.15% of its overall portfolio holdings.

Number of Shares

45,585

Previous 46,222 1.38%

Holding current value

$925,831

Previous $667,000 28.49%

% of portfolio

0.15%

Previous 0.12%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$13.78 - $18.8 $8,777 - $11,975	-637 Reduced 1.38%	45,585 $857,000
Q4 2023 Jan 11, 2024	SELL	$10.95 - $17.32 $69,094 - $109,289	-6,310 Reduced 12.01%	46,222 $667,000
Q3 2023 Oct 12, 2023	SELL	$16.59 - $23.77 $39,699 - $56,881	-2,393 Reduced 4.36%	52,532 $912,000
Q2 2023 Jul 07, 2023	SELL	$19.27 - $24.63 $2,389 - $3,054	-124 Reduced 0.23%	54,925 $1.14 Million
Q1 2023 Apr 06, 2023	SELL	$21.42 - $32.08 $102,430 - $153,406	-4,782 Reduced 7.99%	55,049 $1.3 Million

Q4 2022 Jan 09, 2023	SELL	$23.31 - $28.61 $20,699 - $25,405	-888 Reduced 1.46%	59,831 $1.69 Million
Q3 2022 Oct 12, 2022	SELL	$23.4 - $34.25 $1,895 - $2,774	-81 Reduced 0.13%	60,719 $1.42 Million
Q2 2022 Jul 11, 2022	SELL	$31.66 - $38.9 $24,251 - $29,797	-766 Reduced 1.24%	60,800 $2.05 Million
Q1 2022 Apr 25, 2022	BUY	$30.45 - $39.36 $9,561 - $12,359	314 Added 0.51%	61,566 $2.15 Million
Q4 2021 Jan 20, 2022	SELL	$28.67 - $37.13 $97,793 - $126,650	-3,411 Reduced 5.28%	61,252 $1.87 Million
Q3 2021 Oct 26, 2021	BUY	$28.63 - $35.64 $88,638 - $110,341	3,096 Added 5.03%	64,663 $2.12 Million
Q2 2021 Jul 21, 2021	BUY	$28.45 - $38.0 $1.75 Million - $2.34 Million	61,567 New	61,567 $1.86 Million

Others Institutions Holding OGN

# of Institutions

787

Shares Held

190M

Call Options Held

2.46M

Put Options Held

2.27M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $5.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Account

Radnor Capital Management, LLC Organon & Co. Transaction History